Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_assertion type Assertion NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_head.
- NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_assertion wasGeneratedBy ECO_0000203 NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_provenance.
- NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_assertion wasDerivedFrom befree-20150227 NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_provenance.
- NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_assertion SIO_000772 1726707 NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_provenance.
- NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_assertion evidence source_evidence_literature NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_provenance.
- NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_provenance.